Antipsychotic medication
In workbook 2 antipsychotic medication was discussed. There has been much focus on how and when antipsychotic medication for people with dementia is used. Several studies have highlighted concern and indicated significant risks relating to their use.
There have been many non pharmacological interventions described throughout this workbook. You will remember that anti psychotic medication should be considered only once all other non pharmacological interventions have been considered. (refer to NICE Guideline at www.nice.org.uk/guidance/TA217)
In 2009 an independent clinical review of the use of anti-psychotic drugs was published (Banerjee 2009). Several recommendations came from this report including:
Recommendation 7: There is a need to develop a curriculum for the development of appropriate skills for care home staff in the non-pharmacological treatment of behavioural disorder in dementia, including the deployment of specific therapies with positive impact.
Further learning
- Professor Sube Banerjee. (2009) The use of antipsychotic medication for people with dementia: Time for action. A report for the Minister of State for Care Services. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_108303
STAR Initiative
The STAR initiative was developed by Cornwall and Isles of Scilly Primary Care Trust, Royal Cornwall Hospitals NHS Trust and Cornwall Care in 2010. It was developed in response national and local recognition of the overuse of medications prescribed to people with dementia and the impact that these drugs may have on physical health and quality of life.
It provides an educational toolkit aimed at reducing the use of inappropriate medication in people with dementia. Within this information there are practical observation tools and a ‘3 monthly’ checklist to review, monitor and reduce the prescribing of medication
Further learning
- NHS Cornwall and Isles of Scilly (2011) Cornwall leads on reforming care of dementia patients (Press release). http://www.cornwallandislesofscilly.nhs.uk/CornwallAndIslesOfScillyPCT/MediaCentre/NewsArticles/050411Cornwallleadsondementiacare.aspx
Acetylcholinesterase (AchE) Medication and Memantine
These medications do not ‘cure’ dementia but in certain cases can help to slow down the rate of progression of the illness.
In March 2011 a review and re-appraisal of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease resulted in a change in NICE guidance. Specifically:
- Donepezil, galantamine and rivastigmine are recommended as options for managing mild as well as moderate Alzheimer’s disease, and
- Memantine is recommended as an option for managing moderate Alzheimer’s disease for people who cannot take donepezil, galantamine or rivastigmine and as an option for the later stages of Alzheimer’s disease
Further learning
- Alzheimer’s Society leaflet on treating and caring for people experiencing challenging behaviour and how to reduce the use of antipsychotic drugs http://alzheimers.org.uk/site/scripts/download_info.php?fileID=1133
- NICE Guidance – Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease (technology appraisal guidance TA217) www.nice.org.uk/guidance/TA217
Further learning resources «» Next
